Depression and Anxiety Trial, Not Yet Recruiting NCT06964503 Sponsor: The First Affiliated Hospital of Guangzhou Medical University Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Not Yet Recruiting

NCT06964503
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

Advanced Stage Group:

  • People aged 18 or older
  • People with a confirmed diagnosis of lung cancer (either non-small cell or small cell lung cancer)
  • People whose lung cancer is at an advanced stage (stage IIIB–IV) that cannot be surgically removed, has spread, or has come back
  • People who are generally well enough to carry out light activity and care for themselves (a standard health and activity rating of 0–1)
  • People who have not yet received any systemic cancer treatment such as chemotherapy, targeted therapy, anti-angiogenic therapy, or immunotherapy
  • People who have at least one area of cancer that can be measured on scans according to standard criteria
  • People who are willing and able to give consent to take part in the study

Early-Stage Surgical Group:

  • People aged 18 or older
  • People with a confirmed diagnosis of non-small cell lung cancer (NSCLC)
  • People whose cancer has been confirmed as early stage (stage IA–IIIA)
  • People for whom a tumour tissue sample is available
  • People who have not yet received any systemic cancer treatment such as chemotherapy, targeted therapy, anti-angiogenic therapy, or immunotherapy
  • People who are scheduled to undergo surgery to remove the cancer
  • People who are willing and able to give consent to take part in the study

Neoadjuvant Therapy Group (treatment given before surgery):

  • People aged 18 or older
  • People with a confirmed diagnosis of non-small cell lung cancer (NSCLC)
  • People whose cancer is at stage IB–IIIB and is considered potentially removable by surgery after pre-surgery treatment
  • People who have at least one area of cancer that can be measured on scans according to standard criteria
  • People who are planned to receive, or are already receiving, pre-surgery systemic treatment (such as chemotherapy, targeted therapy, or immunotherapy) with the goal of curing the cancer
  • People who are generally well enough to carry out light activity and care for themselves (a standard health and activity rating of 0–1) before starting pre-surgery treatment
  • People who have not received any systemic cancer treatment before starting pre-surgery treatment
  • People who are willing and able to give consent to take part in the study

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

(Applies to all three groups)

  • People who have had another type of cancer in the past 3 years
  • People who currently have an acute or ongoing mental health condition
  • People who are currently receiving treatment for depression or anxiety
  • People who have previously taken part in another clinical drug trial
  • People who are unable to complete psychological questionnaire assessments

Advanced Stage Group only:

  • People who have brain metastases (cancer that has spread to the brain) that are causing symptoms

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
The First Affiliated Hospital of Guangzhou Medical University
Registry
ClinicalTrials.gov
Start date
30 May 2025
Est. completion
30 May 2030

Primary endpoints

Advanced Stage Cohort: Progression-free survival (PFS); Early-Stage Surgical Cohort: Disease-free survival (DFS); neoadjuvant therapy Cohort: Pathologic complete response (pCR) rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov